Village Farms International, Inc. (“Village Farms” or the
“Company”) (NASDAQ: VFF) today reported its financial results for
the second quarter ended June 30, 2024. All figures are in U.S.
dollars unless otherwise indicated.
Management Commentary
“We are driving strong momentum in our Canadian
Cannabis business by building on our undisputed leadership in dried
flower to further close in on the number one market share position
nationally1,” commented Michael DeGiglio, President and Chief
Executive Officer, Village Farms International. “During the second
quarter, we grew retail branded sales by 35%. Notably, we have
solidified our number two national market share rank in pre-rolls
and further strengthened share in key provinces1. In 12 months, we
have improved to number two in British Columbia (from four) and
number four in Alberta (from eight) and have maintained our number
one position in Ontario and number two position in Quebec1.”
“In our non-branded channel, we continued to
take advantage of a favourable wholesale market to further reduce
non-brand-spec inventory, which again impacted gross margin but
drives cash flow. It was also another solid quarter for export
sales as we remain on track to deliver year-over-year growth this
year. We expect production to start in just a few months in the
Netherlands and we look forward to our first sales in the first
quarter of next year.”
“In our fresh produce business, during the
quarter we expanded third-party supply to strategically support the
long-term growth and health of our produce business. Our cost
management and efficiency initiatives drove a year-to-date
improvement in gross profit compared to last year, offsetting
second quarter margin pressure due to softer than expected market
pricing.”
“Looking ahead, our steady execution is driving
sustained growth in our Canadian Cannabis business, with gains
across our brands, form factors and geographies, as we look to
benefit from multiple, near-term growth opportunities
internationally. In Fresh Produce, we expect continued
yield-focused initiatives, cost improvements and the current
recovery in market pricing should generate significantly improved
performance in both the third and fourth quarters of this year and
position the business well for the future.”
1. Based on estimated retail sales from HiFyre, other third
parties and provincial boards.
Second Quarter Financial
Highlights(All comparable periods are for the
second quarter of 2023 unless otherwise stated)
Consolidated
- Consolidated sales increased 19% year-over-year to $92.1
million from $77.2 million;
- Consolidated net loss was ($23.5 million), or ($0.21) per
share, compared with ($1.4 million), or ($0.01) per share;
- Excluding the ($11.9 million) goodwill and intangible asset
impairment related to U.S. Cannabis, adjusted net loss was ($11.6
million);
- Consolidated adjusted EBITDA (a non-GAAP measure) was ($3.6
million) from $4.5 million; and,
- Consolidated cash flow from operations improved to $5.7 million
from cash used in operations of $1.6 million.
Canadian Cannabis (Pure Sunfarms and Rose
LifeScience)
- Net sales increased 45% to $40.7 million (C$55.8 million) from
$28.1 million (C$37.7 million);
- Retail branded sales increased 38%, international (export)
sales increased 11%, non-branded (wholesale) sales increased 190%
(in Canadian dollars);
- Gross margin was 26% compared with 38%; (in Canadian dollars).
This quarter’s gross margin was reduced by sales of non-brand-spec
inventory in the non-branded channel:
- Net income increased to $1.4 million (C$1.9 million) from $1.2
million (C$1.7 million);
- Adjusted EBITDA was $4.8 million (C$6.6 million) compared with
$4.8 million (C$6.7 million); and,
- Cash flow from operations increased 38% to $5.4 million (C$7.2
million) from $3.1 million (C$5.2 million).
U.S. Cannabis (Balanced Health Botanicals)
- Net sales were $4.3 million compared with $5.3 million;
- Gross margin was 61% compared with 67%;
- Net loss was ($12.3 million) compared with a net income of $0.2
million;
- Excluding the ($11.9 million) impairment of goodwill and
intangible assets, adjusted net loss was ($0.4 million); and,
- Adjusted EBITDA was ($0.2 million) compared with $0.4
million.
Village Farms Fresh
(Produce)
- Sales increased 7% to $47.1 million from $43.8 million;
- Net loss was ($8.3 million) compared with a net loss of ($0.7
million);
- Adjusted EBITDA was ($6.4 million) compared with $1.3 million,
with last year’s quarter benefitting from a favourable legal
settlement of $5.6 million; and,
- Year-to-date, gross loss improved to ($854) from ($2,146),
benefitting from cost management and efficiency initiatives.
Strategic Growth and Operational
Highlights
Canadian Cannabis
- Further expanded its number two national market share
position1, further narrowing the gap to the number one position and
achieving our highest national market share position to date;
- Was the only LP among the top five to expand its national
market share position sequentially1;
- Further expanded its number one national market share position
in dried flower1;
- Expanded its number two national market share position in the
pre-roll category1;
- Continued to achieve steady market share gains in British
Columbia (moving up two positions to be tied for the number two
position) and Alberta, moving up four positions to the number four
position, in the last year1;
- The Supertoast brand was the third fastest growing brand
nationally for the first half of 2024 with 20% market share in the
milled category nationally, despite being sold in only four
provinces2;
- Village Farms' products held the number one position in the
flower category during both the first and second quarters of
20242;
- Launched Hi-Def Pre-Rolls, a first-of-its-kind pre-roll,
featuring pure ground flower optimized for high potency, with THC
content between 36 to 44%, with no concentrates, infusions or
kief.
1.For the second quarter of 2024. Based on estimated retail
sales from HiFyre, other third parties and provincial
boards.2.Based on estimated retail sales from HiFyre, other third
parties and provincial boards.
International Cannabis
- Continued the build-out of the Company’s first indoor cannabis
production facility in Drachten, The Netherlands for the Dutch
recreational cannabis program, with production on track to begin in
the fourth quarter of 2024. The Dutch Program recently completed
its start-up phase, expanded the number of municipalities in which
regulated cannabis can be sold in “coffee shops” from two to
ten.
U.S. Cannabis
- Completed internalization of gummy production, which will
support consistency of supply and gross profit;
- Balanced Health’s CBDistillery reported study results
demonstrating its shhh+ Distilled THC + CBN Deep Sleep
Gummies help users to achieve better-quality rest, fall back
to sleep during the night and wake up feeling refreshed; and,
- The Company’s application for a Texas medicinal marijuana
license remains pending review by the Department of Public
Services. If awarded, the Company plans to work with its
listing authority to structure an acceptable ownership
structure.
VF Fresh (Produce)
- Continued improvement in our Texas greenhouse operations
resulting in a year-over-year decrease in cost per pound due to
ongoing labor efficiencies and increased yields;
- Entered into a strategic agreement to expand third-party
supply;
- Implementing new cultivation technologies, including artificial
intelligence, to drive further operational improvements;
- Amended and extended the credit agreement for the Company’s
C$10 million revolving line with a Canadian chartered bank.
Amendments include expansion of the Company’s borrowing options to
provide additional financial flexibility and the maturity date was
extended from May 24, 2024 to May 24, 2027; and,
- The Company has an ongoing sale process for its Monahans
(Permian Basin, Texas) greenhouse facility. It is also evaluating
other uses for the site and facility, some of which are outside its
historical produce business.
Village Farms Clean Energy
- In April 2024, the Delta, British Columbia Renewable Natural
Gas Project began operations, which commenced the Company’s royalty
revenue stream and began contributing incremental profit to the
Company.
Corporate
- Increased ownership of Rose by 10% to hold an 80% interest,
with the purchase being immediately accretive to adjusted EBITDA
and net income;
- Appointed finance and operations veteran, Carolyn
Hauger, to the Board of Directors; and,
- Approved the appointment of KPMG LLP as the Company’s
independent registered public accounting firm for the year ending
December 31, 2024.
Canadian Cannabis Performance
Summary
(millions except %
metrics) |
Three Months Ended June 30, |
|
|
|
2024 |
2023 |
|
|
|
CAD $ |
|
USD $ |
|
CAD $ |
|
USD $ |
|
Change of CAD $ |
Total Net Sales |
$55.8 |
|
$40.7 |
|
$37.7 |
|
$28.1 |
|
48% |
|
Total Cost of Sales |
$41.1 |
|
$30.0 |
|
$23.3 |
|
$17.3 |
|
76% |
|
Gross Profit |
$14.7 |
|
$10.7 |
|
$14.4 |
|
$10.8 |
|
2% |
|
Gross Margin % |
26% |
|
26% |
|
38% |
|
38% |
|
-31% |
|
SG&A |
$12.0 |
|
$8.7 |
|
$10.5 |
|
$7.8 |
|
14% |
|
Net income (loss) |
$1.9 |
|
$1.4 |
|
$1.7 |
|
$1.2 |
|
12% |
|
Adjusted EBITDA (1) |
$6.6 |
|
$4.8 |
|
$6.7 |
|
$4.8 |
|
-1% |
|
Adjusted EBITDA Margin
(1) |
12% |
|
12% |
|
18% |
|
18% |
|
-33% |
|
Cash Flow from Operations |
$7.2 |
|
$5.4 |
|
$4.7 |
|
$3.1 |
|
38% |
|
|
|
|
|
|
|
|
|
|
|
(millions except %
metrics) |
Six Months Ended June 30, |
|
|
|
2024 |
2023 |
|
|
|
CAD $ |
|
USD $ |
|
CAD $ |
|
USD $ |
|
Change of CAD $ |
Total Net Sales |
$106.3 |
|
$78.2 |
|
$71.7 |
|
$53.2 |
|
48% |
|
Total Cost of Sales |
$78.8 |
|
$58.0 |
|
$45.8 |
|
$34.0 |
|
72% |
|
Gross Profit |
$27.5 |
|
$20.2 |
|
$25.9 |
|
$19.2 |
|
6% |
|
Gross Margin % |
26% |
|
26% |
|
36% |
|
36% |
|
-28% |
|
SG&A |
$22.4 |
|
$16.5 |
|
$19.8 |
|
$14.7 |
|
13% |
|
Net income (loss) |
$3.0 |
|
$2.2 |
|
$1.5 |
|
$1.1 |
|
100% |
|
Adjusted EBITDA (1) |
$12.1 |
|
$8.9 |
|
$12.3 |
|
$8.7 |
|
-2% |
|
Adjusted EBITDA Margin
(1) |
11% |
|
11% |
|
17% |
|
17% |
|
-34% |
|
Cash Flow from Operations |
$13.3 |
|
$9.8 |
|
$9.9 |
|
$7.6 |
|
34% |
|
|
|
|
|
|
|
|
|
|
|
|
1 Adjusted EBITDA is not a recognized earnings
measure and does not have a standard meaning prescribed in by
GAAP.
Canadian Cannabis’ Composition of Sales
by Channel
(millions except %
metrics) |
Three Months Ended June 30, |
|
|
|
2024 |
2023 |
|
|
|
CAD $ |
|
USD $ |
|
CAD $ |
|
USD $ |
|
Change of CAD $ |
Retail Branded Sales |
$68.9 |
|
$50.3 |
|
$49.9 |
|
$37.2 |
|
38% |
|
International Sales |
$2.1 |
|
$1.5 |
|
$1.9 |
|
$1.4 |
|
11% |
|
Non-Branded Sales |
$11.3 |
|
$8.3 |
|
$3.9 |
|
$2.9 |
|
190% |
|
Other |
$0.6 |
|
$0.4 |
|
$0.8 |
|
$0.6 |
|
-25% |
|
Less: Excise Taxes |
($27.1) |
|
($19.8) |
|
($18.8) |
|
($14.0) |
|
44% |
|
Net Sales |
$55.8 |
|
$40.7 |
|
$37.7 |
|
$28.1 |
|
48% |
|
|
|
|
|
|
|
|
|
|
|
(millions except %
metrics) |
Six Months Ended June 30, |
|
|
|
2024 |
2023 |
|
|
|
CAD $ |
|
USD $ |
|
CAD $ |
|
USD $ |
|
Change of CAD $ |
Retail Branded Sales |
$134.7 |
|
$99.1 |
|
$96.6 |
|
$71.7 |
|
39% |
|
International Sales |
$4.1 |
|
$3.0 |
|
$4.1 |
|
$3.1 |
|
0% |
|
Non-Branded Sales |
$20.0 |
|
$14.7 |
|
$7.1 |
|
$5.2 |
|
182% |
|
Other |
$1.2 |
|
$0.9 |
|
$1.3 |
|
$0.9 |
|
-8% |
|
Less: Excise Taxes |
($53.7) |
|
($39.5) |
|
($37.4) |
|
($27.7) |
|
44% |
|
Net Sales |
$106.3 |
|
$78.2 |
|
$71.7 |
|
$53.2 |
|
48% |
|
|
|
|
|
|
|
|
|
|
|
|
Presentation of Financial Results
The Company’s financial statements for the three
and six months ended June 30, 2024, as well as the comparative
periods for 2023, have been prepared and presented under United
States Generally Accepted Accounting Principals (“GAAP”).
RESULTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts, and
unless otherwise noted)
Consolidated Financial Performance
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Sales |
$ |
92,182 |
|
|
$ |
77,212 |
|
|
$ |
170,259 |
|
|
$ |
141,868 |
|
Cost of sales |
|
(82,934 |
) |
|
|
(65,713 |
) |
|
|
(145,498 |
) |
|
|
(118,069 |
) |
Gross profit |
|
9,248 |
|
|
|
11,499 |
|
|
|
24,761 |
|
|
|
23,799 |
|
Selling, general and
administrative expenses |
|
(19,666 |
) |
|
|
(16,753 |
) |
|
|
(36,053 |
) |
|
|
(34,158 |
) |
Interest expense |
|
(905 |
) |
|
|
(1,411 |
) |
|
|
(1,822 |
) |
|
|
(2,544 |
) |
Interest income |
|
322 |
|
|
|
283 |
|
|
|
528 |
|
|
|
479 |
|
Foreign exchange (loss)
gain |
|
(403 |
) |
|
|
738 |
|
|
|
(1,281 |
) |
|
|
669 |
|
Other income |
|
45 |
|
|
|
5,602 |
|
|
|
149 |
|
|
|
5,632 |
|
Goodwill and intangible asset
impairments (1) |
|
(11,939 |
) |
|
|
— |
|
|
|
(11,939 |
) |
|
|
— |
|
Loss before taxes |
|
(23,298 |
) |
|
|
(42 |
) |
|
|
(25,657 |
) |
|
|
(6,123 |
) |
Provision for income
taxes |
|
(260 |
) |
|
|
(1,299 |
) |
|
|
(580 |
) |
|
|
(1,933 |
) |
Loss including non-controlling
interests |
|
(23,558 |
) |
|
|
(1,341 |
) |
|
|
(26,237 |
) |
|
|
(8,056 |
) |
Less: net loss (income)
attributable to non-controlling interests, net of tax |
|
9 |
|
|
|
(39 |
) |
|
|
(164 |
) |
|
|
40 |
|
Net loss attributable to
Village Farms International, Inc. shareholders |
$ |
(23,549 |
) |
|
$ |
(1,380 |
) |
|
$ |
(26,401 |
) |
|
$ |
(8,016 |
) |
Adjusted EBITDA (2) |
$ |
(3,559 |
) |
|
$ |
4,475 |
|
|
$ |
32 |
|
|
$ |
4,994 |
|
Basic loss per share |
$ |
(0.21 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.24 |
) |
|
$ |
(0.07 |
) |
Diluted loss per share |
$ |
(0.21 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.24 |
) |
|
$ |
(0.07 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Reflects impairment to goodwill and
intangibles of $11,939 in U.S. Cannabis that was based on recent
historical performance, near-term forecasts, and the state of the
CBD industry in the United States. See “Critical Accounting
Estimates and Judgments” below for more information.(2) Adjusted
EBITDA is not a recognized earnings measure and does not have a
standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA
may not be comparable to similar measures presented by other
issuers. Management believes that Adjusted EBITDA is a useful
supplemental measure in evaluating the performance of the Company
because it excludes non-recurring and other items that do not
reflect our business performance. Adjusted EBITDA includes the
Company’s 70% interest in Rose LifeScience through March 31, 2024,
80% interest in Rose LifeScience beginning on April 1, 2024 and 85%
interest in Leli.
We caution that our results of operations for
the three and six months ended June 30, 2024, and 2023 may not be
indicative of our future performance.
SEGMENTED RESULTS OF OPERATIONS
(In thousands of U.S. dollars, except per share
amounts, and unless otherwise noted)
|
For The Three Months Ended June 30, 2024 |
|
|
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Sales |
$ |
47,019 |
|
|
$ |
40,745 |
|
|
$ |
4,297 |
|
|
$ |
121 |
|
|
$ |
— |
|
|
$ |
92,182 |
|
Cost of sales |
|
(51,183 |
) |
|
|
(30,040 |
) |
|
|
(1,668 |
) |
|
|
(43 |
) |
|
|
— |
|
|
|
(82,934 |
) |
Selling, general and
administrative expenses |
|
(3,613 |
) |
|
|
(8,749 |
) |
|
|
(2,960 |
) |
|
|
(17 |
) |
|
|
(4,327 |
) |
|
|
(19,666 |
) |
Other expense, net |
|
(527 |
) |
|
|
(270 |
) |
|
|
— |
|
|
|
— |
|
|
|
(144 |
) |
|
|
(941 |
) |
Goodwill and intangible asset
impairments (1) |
|
— |
|
|
|
— |
|
|
|
(11,939 |
) |
|
|
— |
|
|
|
— |
|
|
|
(11,939 |
) |
Operating (loss) income |
|
(8,304 |
) |
|
|
1,686 |
|
|
|
(12,270 |
) |
|
|
61 |
|
|
|
(4,471 |
) |
|
|
(23,298 |
) |
Recovery of (provision for)
income taxes |
|
4 |
|
|
|
(259 |
) |
|
|
— |
|
|
|
— |
|
|
|
(5 |
) |
|
|
(260 |
) |
(Loss) income from
consolidated entities |
|
(8,300 |
) |
|
|
1,427 |
|
|
|
(12,270 |
) |
|
|
61 |
|
|
|
(4,476 |
) |
|
|
(23,558 |
) |
Less: net (income) loss
attributable to non-controlling interests, net of tax |
|
— |
|
|
|
(43 |
) |
|
|
— |
|
|
|
— |
|
|
|
52 |
|
|
|
9 |
|
Net (loss) income |
$ |
(8,300 |
) |
|
$ |
1,384 |
|
|
$ |
(12,270 |
) |
|
$ |
61 |
|
|
$ |
(4,424 |
) |
|
$ |
(23,549 |
) |
Adjusted EBITDA (2) |
$ |
(6,350 |
) |
|
$ |
4,818 |
|
|
$ |
(240 |
) |
|
$ |
61 |
|
|
$ |
(1,848 |
) |
|
$ |
(3,559 |
) |
Basic (loss) income per
share |
$ |
(0.07 |
) |
|
$ |
0.01 |
|
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.04 |
) |
|
$ |
(0.21 |
) |
Diluted (loss) income per
share |
$ |
(0.07 |
) |
|
$ |
0.01 |
|
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.04 |
) |
|
$ |
(0.21 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Three Months Ended June 30, 2023 |
|
|
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Sales |
$ |
43,846 |
|
|
$ |
28,065 |
|
|
$ |
5,301 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
77,212 |
|
Cost of sales |
|
(46,607 |
) |
|
|
(17,349 |
) |
|
|
(1,743 |
) |
|
|
(14 |
) |
|
|
— |
|
|
|
(65,713 |
) |
Selling, general and
administrative expenses |
|
(2,854 |
) |
|
|
(7,827 |
) |
|
|
(3,386 |
) |
|
|
(1 |
) |
|
|
(2,685 |
) |
|
|
(16,753 |
) |
Other income (expense),
net |
|
5,135 |
|
|
|
(806 |
) |
|
|
— |
|
|
|
(19 |
) |
|
|
902 |
|
|
|
5,212 |
|
Operating (loss) income |
|
(480 |
) |
|
|
2,083 |
|
|
|
172 |
|
|
|
(34 |
) |
|
|
(1,783 |
) |
|
|
(42 |
) |
Provision for income
taxes |
|
(218 |
) |
|
|
(818 |
) |
|
|
— |
|
|
|
— |
|
|
|
(263 |
) |
|
|
(1,299 |
) |
(Loss) income from
consolidated entities |
|
(698 |
) |
|
|
1,265 |
|
|
|
172 |
|
|
|
(34 |
) |
|
|
(2,046 |
) |
|
|
(1,341 |
) |
Less: net (income) loss
attributable to non-controlling interests, net of tax |
|
— |
|
|
|
(91 |
) |
|
|
— |
|
|
|
— |
|
|
|
52 |
|
|
|
(39 |
) |
Net (loss) income |
$ |
(698 |
) |
|
$ |
1,174 |
|
|
$ |
172 |
|
|
$ |
(34 |
) |
|
$ |
(1,994 |
) |
|
$ |
(1,380 |
) |
Adjusted EBITDA (2) |
$ |
1,330 |
|
|
$ |
4,778 |
|
|
$ |
354 |
|
|
$ |
(35 |
) |
|
$ |
(1,952 |
) |
|
$ |
4,475 |
|
Basic (loss) income per
share |
$ |
(0.01 |
) |
|
$ |
0.01 |
|
|
$ |
0.00 |
|
|
$ |
(0.00 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.01 |
) |
Diluted (loss) income per
share |
$ |
(0.01 |
) |
|
$ |
0.01 |
|
|
$ |
0.00 |
|
|
$ |
(0.00 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.01 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Six Months Ended June 30, 2024 |
|
|
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Sales |
$ |
83,113 |
|
|
$ |
78,191 |
|
|
$ |
8,834 |
|
|
$ |
121 |
|
|
$ |
— |
|
|
$ |
170,259 |
|
Cost of sales |
|
(83,967 |
) |
|
|
(57,978 |
) |
|
|
(3,510 |
) |
|
|
(43 |
) |
|
|
— |
|
|
|
(145,498 |
) |
Selling, general and
administrative expenses |
|
(6,306 |
) |
|
|
(16,453 |
) |
|
|
(6,366 |
) |
|
|
(37 |
) |
|
|
(6,891 |
) |
|
|
(36,053 |
) |
Other expense, net |
|
(1,030 |
) |
|
|
(671 |
) |
|
|
— |
|
|
|
— |
|
|
|
(725 |
) |
|
|
(2,426 |
) |
Goodwill and intangible asset
impairments (1) |
|
— |
|
|
|
— |
|
|
|
(11,939 |
) |
|
|
— |
|
|
|
— |
|
|
|
(11,939 |
) |
Operating (loss) income |
|
(8,190 |
) |
|
|
3,089 |
|
|
|
(12,981 |
) |
|
|
41 |
|
|
|
(7,616 |
) |
|
|
(25,657 |
) |
Recovery of (provision for)
income taxes |
|
4 |
|
|
|
(588 |
) |
|
|
— |
|
|
|
— |
|
|
|
4 |
|
|
|
(580 |
) |
(Loss) income from
consolidated entities |
|
(8,186 |
) |
|
|
2,501 |
|
|
|
(12,981 |
) |
|
|
41 |
|
|
|
(7,612 |
) |
|
|
(26,237 |
) |
Less: net (income) loss
attributable to non-controlling interests, net of tax |
|
— |
|
|
|
(270 |
) |
|
|
— |
|
|
|
— |
|
|
|
106 |
|
|
|
(164 |
) |
Net (loss) income |
$ |
(8,186 |
) |
|
$ |
2,231 |
|
|
$ |
(12,981 |
) |
|
$ |
41 |
|
|
$ |
(7,506 |
) |
|
$ |
(26,401 |
) |
Adjusted EBITDA (2) |
$ |
(4,322 |
) |
|
$ |
8,891 |
|
|
$ |
(855 |
) |
|
$ |
41 |
|
|
$ |
(3,723 |
) |
|
$ |
32 |
|
Basic (loss) income per
share |
$ |
(0.07 |
) |
|
$ |
0.02 |
|
|
$ |
(0.12 |
) |
|
$ |
0.00 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.24 |
) |
Diluted (loss) income per
share |
$ |
(0.07 |
) |
|
$ |
0.02 |
|
|
$ |
(0.12 |
) |
|
$ |
0.00 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.24 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Six Months Ended June 30, 2023 |
|
|
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Sales |
$ |
78,413 |
|
|
$ |
53,177 |
|
|
$ |
10,278 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
141,868 |
|
Cost of sales |
|
(80,559 |
) |
|
|
(34,007 |
) |
|
|
(3,482 |
) |
|
|
(21 |
) |
|
|
— |
|
|
|
(118,069 |
) |
Selling, general and
administrative expenses |
|
(5,770 |
) |
|
|
(14,675 |
) |
|
|
(7,003 |
) |
|
|
(30 |
) |
|
|
(6,680 |
) |
|
|
(34,158 |
) |
Other income (expense)
net |
|
4,591 |
|
|
|
(1,410 |
) |
|
|
3 |
|
|
|
(19 |
) |
|
|
1,071 |
|
|
|
4,236 |
|
Operating (loss) income |
|
(3,325 |
) |
|
|
3,085 |
|
|
|
(204 |
) |
|
|
(70 |
) |
|
|
(5,609 |
) |
|
|
(6,123 |
) |
Recovery of (provision for)
income taxes |
|
8 |
|
|
|
(1,956 |
) |
|
|
— |
|
|
|
— |
|
|
|
15 |
|
|
|
(1,933 |
) |
(Loss) income from
consolidated entities |
|
(3,317 |
) |
|
|
1,129 |
|
|
|
(204 |
) |
|
|
(70 |
) |
|
|
(5,594 |
) |
|
|
(8,056 |
) |
Less: net (income) loss
attributable to non-controlling interests, net of tax |
|
— |
|
|
|
(60 |
) |
|
|
— |
|
|
|
— |
|
|
|
100 |
|
|
|
40 |
|
Net (loss) income |
$ |
(3,317 |
) |
|
$ |
1,069 |
|
|
$ |
(204 |
) |
|
$ |
(70 |
) |
|
$ |
(5,494 |
) |
|
$ |
(8,016 |
) |
Adjusted EBITDA (2) |
$ |
335 |
|
|
$ |
8,688 |
|
|
$ |
203 |
|
|
$ |
(71 |
) |
|
$ |
(4,161 |
) |
|
$ |
4,994 |
|
Basic (loss) income per
share |
$ |
(0.03 |
) |
|
$ |
0.01 |
|
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.07 |
) |
Diluted (loss) income per
share |
$ |
(0.03 |
) |
|
$ |
0.01 |
|
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.07 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Reflects impairment to goodwill and
intangibles of $11,939 in U.S. Cannabis that was based on recent
historical performance, near-term forecasts, and the state of the
CBD industry in the United States. See “Critical Accounting
Estimates and Judgments” below for more information.(2) Adjusted
EBITDA is not a recognized earnings measure and does not have a
standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA
may not be comparable to similar measures presented by other
issuers. Management believes that Adjusted EBITDA is a useful
supplemental measure in evaluating the performance of the Company
because it excludes non-recurring and other items that do not
reflect our business performance. Adjusted EBITDA includes the
Company’s 70% interest in Rose LifeScience through March 31, 2024,
80% interest in Rose LifeScience beginning on April 1, 2024 and 85%
interest in Leli.
A detailed discussion of our consolidated and
segment results can be found in the 10Q MD&A on the Village
Farms website under Financial Reports
(https://villagefarms.com/financial-reports/) within the Investors
section.
Reconciliation of Net Income to Adjusted
EBITDA
The following tables reflects a reconciliation
of net income to Adjusted EBITDA, as presented by the Company:
|
For The Three Months Ended June 30, 2024 |
|
(in thousands of U.S.
dollars) |
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Net (loss) income |
$ |
(8,300 |
) |
|
$ |
1,384 |
|
|
$ |
(12,270 |
) |
|
$ |
61 |
|
|
$ |
(4,424 |
) |
|
$ |
(23,549 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization |
|
1,347 |
|
|
|
2,545 |
|
|
|
50 |
|
|
|
— |
|
|
|
46 |
|
|
|
3,988 |
|
Foreign currency exchange
gain |
|
29 |
|
|
|
(12 |
) |
|
|
— |
|
|
|
— |
|
|
|
329 |
|
|
|
346 |
|
Interest expense, net |
|
578 |
|
|
|
216 |
|
|
|
— |
|
|
|
— |
|
|
|
(183 |
) |
|
|
611 |
|
(Recovery of) provision for
income taxes |
|
(4 |
) |
|
|
259 |
|
|
|
— |
|
|
|
— |
|
|
|
5 |
|
|
|
260 |
|
Provision for income taxes
attributable to non-controlling interest |
|
— |
|
|
|
(51 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(51 |
) |
Share-based compensation |
|
— |
|
|
|
18 |
|
|
|
41 |
|
|
|
— |
|
|
|
2,113 |
|
|
|
2,172 |
|
Interest expense for JV's |
|
— |
|
|
|
(23 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(23 |
) |
Amortization for JVs |
|
— |
|
|
|
432 |
|
|
|
— |
|
|
|
— |
|
|
|
266 |
|
|
|
698 |
|
Foreign currency exchange gain
for JVs |
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Share-based compensation for
JV's |
|
— |
|
|
|
19 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
19 |
|
Other expense, net for
JV's |
|
— |
|
|
|
29 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
29 |
|
Goodwill and intangible asset
impairments (1) |
|
— |
|
|
|
— |
|
|
|
11,939 |
|
|
|
— |
|
|
|
— |
|
|
|
11,939 |
|
Adjusted EBITDA (2) |
$ |
(6,350 |
) |
|
$ |
4,818 |
|
|
$ |
(240 |
) |
|
$ |
61 |
|
|
$ |
(1,848 |
) |
|
$ |
(3,559 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Three Months Ended June 30, 2023 |
|
(in thousands of U.S.
dollars) |
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Net loss |
$ |
(698 |
) |
|
$ |
1,174 |
|
|
$ |
172 |
|
|
$ |
(34 |
) |
|
$ |
(1,994 |
) |
|
$ |
(1,380 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization |
|
1,302 |
|
|
|
1,494 |
|
|
|
87 |
|
|
|
— |
|
|
|
63 |
|
|
|
2,946 |
|
Foreign currency exchange
gain |
|
(80 |
) |
|
|
(22 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
(663 |
) |
|
|
(766 |
) |
Interest expense (income),
net |
|
588 |
|
|
|
728 |
|
|
|
— |
|
|
|
— |
|
|
|
(237 |
) |
|
|
1,079 |
|
Provision for income
taxes |
|
218 |
|
|
|
818 |
|
|
|
— |
|
|
|
— |
|
|
|
263 |
|
|
|
1,299 |
|
Share-based compensation |
|
— |
|
|
|
119 |
|
|
|
95 |
|
|
|
— |
|
|
|
385 |
|
|
|
599 |
|
Interest expense for JV's |
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
Amortization for JV's |
|
— |
|
|
|
367 |
|
|
|
— |
|
|
|
— |
|
|
|
231 |
|
|
|
598 |
|
Foreign currency exchange loss
for JV's |
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Share-based compensation for
JV's |
|
— |
|
|
|
40 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
40 |
|
Other expenses for JV's |
|
— |
|
|
|
(9 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(9 |
) |
Deferred financing fees |
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
Adjusted EBITDA (2) |
$ |
1,330 |
|
|
$ |
4,778 |
|
|
$ |
354 |
|
|
$ |
(35 |
) |
|
$ |
(1,952 |
) |
|
$ |
4,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Six Months Ended June 30, 2024 |
|
(in thousands of U.S.
dollars) |
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Net (loss) income |
$ |
(8,186 |
) |
|
$ |
2,231 |
|
|
$ |
(12,981 |
) |
|
$ |
41 |
|
|
$ |
(7,506 |
) |
|
$ |
(26,401 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization |
|
2,681 |
|
|
|
4,816 |
|
|
|
104 |
|
|
|
— |
|
|
|
106 |
|
|
|
7,707 |
|
Foreign currency exchange
gain |
|
38 |
|
|
|
15 |
|
|
|
— |
|
|
|
— |
|
|
|
1,064 |
|
|
|
1,117 |
|
Interest expense, net |
|
1,149 |
|
|
|
522 |
|
|
|
— |
|
|
|
— |
|
|
|
(337 |
) |
|
|
1,334 |
|
(Recovery of) provision for
income taxes |
|
(4 |
) |
|
|
588 |
|
|
|
— |
|
|
|
— |
|
|
|
(4 |
) |
|
|
580 |
|
Provision for income taxes
attributable to non-controlling interest |
|
— |
|
|
|
(150 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(150 |
) |
Share-based compensation |
|
— |
|
|
|
40 |
|
|
|
83 |
|
|
|
— |
|
|
|
2,421 |
|
|
|
2,544 |
|
Interest expense for JV's |
|
— |
|
|
|
(31 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(31 |
) |
Amortization for JVs |
|
— |
|
|
|
799 |
|
|
|
— |
|
|
|
— |
|
|
|
533 |
|
|
|
1,332 |
|
Foreign currency exchange gain
for JVs |
|
— |
|
|
|
5 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
5 |
|
Share-based compensation for
JV's |
|
— |
|
|
|
42 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
42 |
|
Other expense, net for
JV's |
|
— |
|
|
|
4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
Deferred financing fees |
|
— |
|
|
|
10 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10 |
|
Goodwill and
intangible asset impairments (1) |
— |
|
|
|
— |
|
|
|
11,939 |
|
|
|
— |
|
|
|
— |
|
|
|
11,939 |
|
Adjusted EBITDA (2) |
$ |
(4,322 |
) |
|
$ |
8,891 |
|
|
$ |
(855 |
) |
|
$ |
41 |
|
|
$ |
(3,723 |
) |
|
$ |
32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Six Months Ended June 30, 2023 |
|
(in thousands of U.S.
dollars) |
VF Fresh (Produce) |
|
|
Cannabis Canada |
|
|
Cannabis U.S. |
|
|
Clean Energy |
|
|
Corporate |
|
|
Total |
|
Net (loss) income |
$ |
(3,317 |
) |
|
$ |
1,069 |
|
|
$ |
(204 |
) |
|
$ |
(70 |
) |
|
$ |
(5,494 |
) |
|
$ |
(8,016 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization |
|
2,556 |
|
|
|
3,284 |
|
|
|
226 |
|
|
|
— |
|
|
|
124 |
|
|
|
6,190 |
|
Foreign currency exchange
(gain) loss |
|
(27 |
) |
|
|
(35 |
) |
|
|
19 |
|
|
|
(1 |
) |
|
|
(689 |
) |
|
|
(733 |
) |
Interest expense (income),
net |
|
1,131 |
|
|
|
1,289 |
|
|
|
(24 |
) |
|
|
— |
|
|
|
(380 |
) |
|
|
2,016 |
|
(Recovery of) provision for
income taxes |
|
(8 |
) |
|
|
1,956 |
|
|
|
— |
|
|
|
— |
|
|
|
(15 |
) |
|
|
1,933 |
|
Share-based compensation |
|
— |
|
|
|
263 |
|
|
|
185 |
|
|
|
— |
|
|
|
1,834 |
|
|
|
2,282 |
|
Interest expense for JV's |
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
Amortization for JV's |
|
— |
|
|
|
699 |
|
|
|
— |
|
|
|
— |
|
|
|
459 |
|
|
|
1,158 |
|
Foreign currency exchange loss
for JV's |
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Share-based compensation for
JV's |
|
— |
|
|
|
74 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
74 |
|
Other expenses for JV's |
|
— |
|
|
|
(15 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(15 |
) |
Deferred financing fees |
|
— |
|
|
|
68 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
68 |
|
Other expense, net |
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Adjusted EBITDA (2) |
$ |
335 |
|
|
$ |
8,688 |
|
|
$ |
203 |
|
|
$ |
(71 |
) |
|
$ |
(4,161 |
) |
|
$ |
4,994 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Reflects impairment to goodwill and intangibles of $11,939
in U.S. Cannabis that was based on recent historical performance,
near-term forecasts, and the state of the CBD industry in the
United States. See “Critical Accounting Estimates and Judgments”
below for more information.(2) Adjusted EBITDA is not a recognized
earnings measure and does not have a standardized meaning
prescribed by GAAP. Therefore, Adjusted EBITDA presented for these
segments may not be comparable to similar measures presented by
other issuers. Management believes that Adjusted EBITDA is a useful
supplemental measure in evaluating the performance of the Company
because it excludes non-recurring and other items that do not
reflect the underlying business performance of the Company.
This press release is intended to be read in
conjunction with the Company’s Consolidated Financial Statements
("Financial Statements”) and MD&A for the three and six months
ended June 30, 2024 in the Company Form 10-Q, which will be filed
on (www.sec.gov/edgar.shtml) and SEDAR (www.sedar.com) and will be
available at www.villagefarms.com.
Conference Call
Village Farms’ management team will host a
conference call to discuss its second quarter financial results
today, Thursday, August 8, 2024, at 8:30 a.m. ET. Participants can
access the conference call via a webcast at Village Farms
Second Quarter 2024 Conference Call Webcast or on the company
website at Village Farms - Events. Participants wanting to
access the conference call by telephone must register in advance
at Village Farms Second Quarter 2024 Conference Call
Registration to receive telephone dial-in information.
The live question and answer session will be
limited to analysts; however, others are invited to submit
questions ahead of the conference call via email at
investorrelations@villagefarms.com. Management will address
questions received via email during the question and answer session
as time permits.
Conference Call Archive Access Information
For those unable to participate in the
conference call at the scheduled time, it will be archived for
replay beginning approximately one hour following completion of the
call on Village Farms’ web site
at http://villagefarms.com/investor-relations/investor-calls.
About Village Farms
International
Village Farms leverages decades of experience as
a large-scale, Controlled Environment Agriculture-based, vertically
integrated supplier for high-value, high-growth plant-based
Consumer Packaged Goods opportunities, with a strong foundation as
a leading fresh produce supplier to grocery and large-format
retailers throughout the US and Canada, and new high-growth
opportunities in the cannabis and CBD categories in North America,
the Netherlands and selected markets internationally.
In Canada, the Company's wholly-owned Canadian
subsidiary, Pure Sunfarms, is one of the single largest cannabis
operations in the world, the lowest-cost greenhouse producer and
one of Canada’s best-selling brands. The Company also owns 80% of
Québec-based, Rose LifeScience, a leading third-party cannabis
products commercialization expert in the Province of Québec.
In the US, wholly-owned Balanced Health
Botanicals is one of the leading CBD brands and e-commerce
platforms in the country. Subject to compliance with all applicable
US federal and state laws and stock exchange rules, Village Farms
plans to enter the US high-THC cannabis market via multiple
strategies, leveraging one of the largest greenhouse operations in
the country (more than 5.5 million square feet in West Texas), as
well as the operational and product expertise gained through Pure
Sunfarms' cannabis success in Canada.
Internationally, Village Farms is targeting
selected, nascent, legal cannabis and CBD opportunities with
significant medium- and long-term potential, with an initial focus
on the Asia-Pacific region and Europe.
Cautionary Statement Regarding
Forward-Looking Information
As used in this Press Release, the terms
“Village Farms”, “Village Farms International”, the “Company”,
“we”, “us”, “our” and similar references refer to Village Farms
International, Inc. and our consolidated subsidiaries, and the term
“Common Shares” refers to our common shares, no par value. Our
financial information is presented in U.S. dollars and all
references in this Press Release to “$” means U.S. dollars and all
references to “C$” means Canadian dollars.
This Press Release contains forward-looking
statements within the meaning of the United States Private
Securities Litigation Reform Act of 1995, Section 27A of the U.S.
Securities Act of 1933, as amended, (the "Securities Act") and
Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and is subject to the safe harbor created by those
sections. This Press Release also contains "forward-looking
information" within the meaning of applicable Canadian securities
laws. We refer to such forward-looking statements and
forward-looking information collectively as "forward-looking
statements". Forward-looking statements may relate to the Company's
future outlook or financial position and anticipated events or
results and may include statements regarding the financial
position, business strategy, budgets, expansion plans, litigation,
projected production, projected costs, capital expenditures,
financial results, taxes, plans and objectives of or involving the
Company. Particularly, statements regarding future results,
performance, achievements, prospects or opportunities for the
Company, the greenhouse vegetable or produce industry, the cannabis
industry and market and our energy segment are forward-looking
statements. In some cases, forward-looking information can be
identified by such terms as "can", "outlook", "may", "might",
"will", "could", "should", "would", "occur", "expect", "plan",
"anticipate", "believe", "intend", "try", "estimate", "predict",
"potential", "continue", "likely", "schedule", "objectives", or the
negative or grammatical variation thereof or other similar
expressions concerning matters that are not historical facts. The
forward-looking statements in this Press Release are subject to
risks that may include, but are not limited to: our limited
operating history in the cannabis and cannabinoids industry,
including that of Pure Sunfarms, Inc. (“Pure Sunfarms”), Rose
LifeScience Inc. (“Rose” or “Rose LifeScience”) and Balanced Health
Botanicals, LLC (“Balanced Health”); the limited operational
history of the Delta RNG Project in our energy segment; the legal
status of the cannabis business of Pure Sunfarms and Rose and the
hemp business of Balanced Health and uncertainty regarding the
legality and regulatory status of cannabis in the United States;
risks relating to the integration of Balanced Health and Rose into
our consolidated business; risks relating to obtaining additional
financing on acceptable terms, including our dependence upon credit
facilities and dilutive transactions; potential difficulties in
achieving and/or maintaining profitability; variability of product
pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids,
and agricultural businesses; our market position and competitive
position; our ability to leverage current business relationships
for future business involving hemp and cannabinoids; the ability of
Pure Sunfarms and Rose to cultivate and distribute cannabis in
Canada; existing and new governmental regulations, including risks
related to regulatory compliance and regarding obtaining and
maintaining licenses required under the Cannabis Act (Canada), the
Criminal Code and other Acts, S.C. 2018, C. 16 (Canada) for its
Canadian operational facilities, and changes in our regulatory
requirements; legal and operational risks relating to expected
conversion of our greenhouses to cannabis production in Canada and
in the United States; risks related to rules and regulations at the
U.S. Federal (Food and Drug Administration and United States
Department of Agriculture), state and municipal levels with respect
to produce and hemp, cannabidiol-based products commercialization;
retail consolidation, technological advances and other forms of
competition; transportation disruptions; product liability and
other potential litigation; retention of key executives; labor
issues; uninsured and underinsured losses; vulnerability to rising
energy costs; inflationary effects on costs of cultivation and
transportation; recessionary effects on demand of our products;
environmental, health and safety risks, foreign exchange exposure,
risks associated with cross-border trade; difficulties in managing
our growth; restrictive covenants under our credit facilities;
natural catastrophes; elevated interest rates; and tax risks.
The Company has based these forward-looking
statements on factors and assumptions about future events and
financial trends that it believes may affect its financial
condition, results of operations, business strategy and financial
needs. Although the forward-looking statements contained in this
Press Release are based upon assumptions that management believes
are reasonable based on information currently available to
management, there can be no assurance that actual results will be
consistent with these forward-looking statements. Forward-looking
statements necessarily involve known and unknown risks and
uncertainties, many of which are beyond the Company's control,
which may cause the Company's or the industry's actual results,
performance, achievements, prospects and opportunities in future
periods to differ materially from those expressed or implied by
such forward-looking statements. These risks and uncertainties
include, among other things, the factors contained in the Company's
filings with securities regulators, including the Company’s most
recently filed Quarterly Report on Form 10-Q and the Company’s most
recently filed annual report on Form 10-K.
When relying on forward-looking statements to
make decisions, the Company cautions readers not to place undue
reliance on these statements, as forward-looking statements involve
significant risks and uncertainties and should not be read as
guarantees of future results, performance, achievements, prospects
and opportunities. The forward-looking statements made in this
Press Release relate only to events or information as of the date
on which the statements are made in this Press Release. Except as
required by law, the Company undertakes no obligation to update or
revise publicly any forward-looking statements, whether as a result
of new information, future events or otherwise, after the date on
which the statements are made or to reflect the occurrence of
unanticipated events.
Contact Information
Lawrence ChamberlainInvestor
RelationsLodeRock Advisors(416)
519-4196lawrence.chamberlain@loderockadvisors.com |
|
|
|
|
|
|
Village Farms International, Inc.
Consolidated Statements of Financial Position
(In thousands of United States dollars, except share
data) (Unaudited) |
|
|
|
|
|
|
|
June 30, 2024 |
|
December 31, 2023 |
ASSETS |
|
|
|
|
Current assets |
|
|
|
|
Cash and cash equivalents |
|
$ |
29,657 |
|
|
$ |
30,291 |
|
Restricted cash |
|
|
— |
|
|
|
5,000 |
|
Trade receivables |
|
|
39,875 |
|
|
|
30,561 |
|
Inventories |
|
|
59,029 |
|
|
|
78,472 |
|
Income tax receivable |
|
|
8 |
|
|
|
— |
|
Other receivables |
|
|
1,087 |
|
|
|
294 |
|
Prepaid expenses and deposits |
|
|
4,678 |
|
|
|
7,150 |
|
Total current assets |
|
|
134,334 |
|
|
|
151,768 |
|
Non-current assets |
|
|
|
|
Property, plant and equipment |
|
|
198,433 |
|
|
|
205,613 |
|
Investments |
|
|
2,656 |
|
|
|
2,656 |
|
Goodwill |
|
|
44,460 |
|
|
|
55,918 |
|
Intangibles |
|
|
27,869 |
|
|
|
32,275 |
|
Deferred tax asset |
|
|
4,201 |
|
|
|
4,201 |
|
Right-of-use assets |
|
|
11,352 |
|
|
|
12,596 |
|
Other assets |
|
|
2,049 |
|
|
|
1,962 |
|
Total assets |
|
$ |
425,354 |
|
|
$ |
466,989 |
|
LIABILITIES |
|
|
|
|
Current liabilities |
|
|
|
|
Line of credit |
|
$ |
4,000 |
|
|
$ |
4,000 |
|
Trade payables |
|
|
20,117 |
|
|
|
21,753 |
|
Current maturities of long-term debt |
|
|
8,683 |
|
|
|
9,133 |
|
Accrued sales taxes |
|
|
15,785 |
|
|
|
15,941 |
|
Accrued loyalty program |
|
|
1,623 |
|
|
|
1,773 |
|
Accrued liabilities |
|
|
13,299 |
|
|
|
15,076 |
|
Lease liabilities - current |
|
|
2,354 |
|
|
|
2,112 |
|
Income tax payable |
|
|
— |
|
|
|
28 |
|
Other current liabilities |
|
|
2,337 |
|
|
|
2,340 |
|
Total current liabilities |
|
|
68,198 |
|
|
|
72,156 |
|
Non-current liabilities |
|
|
|
|
Long-term debt |
|
|
35,736 |
|
|
|
38,925 |
|
Deferred tax liability |
|
|
23,582 |
|
|
|
23,730 |
|
Lease liabilities - non-current |
|
|
9,712 |
|
|
|
11,335 |
|
Other liabilities |
|
|
2,087 |
|
|
|
1,902 |
|
Total liabilities |
|
|
139,315 |
|
|
|
148,048 |
|
MEZZANINE
EQUITY |
|
|
|
|
Redeemable non-controlling interest |
|
|
10,358 |
|
|
|
15,667 |
|
SHAREHOLDERS’
EQUITY |
|
|
|
|
Common stock, no par value per share - unlimited shares authorized;
111,727,953 shares issued and outstanding at June 30, 2024 and
110,248,929 shares issued and outstanding at December 31,
2023. |
|
|
386,719 |
|
|
|
386,719 |
|
Additional paid in capital |
|
|
30,405 |
|
|
|
25,611 |
|
Accumulated other comprehensive loss |
|
|
(9,394) |
|
|
|
(3,540) |
|
Retained earnings |
|
|
(132,566) |
|
|
|
(106,165) |
|
Total Village Farms International, Inc. shareholders’ equity |
|
|
275,164 |
|
|
|
302,625 |
|
Non-controlling interest |
|
|
517 |
|
|
|
649 |
|
Total shareholders’ equity |
|
|
275,681 |
|
|
|
303,274 |
|
Total liabilities, mezzanine equity and shareholders’ equity |
|
$ |
425,354 |
|
|
$ |
466,989 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Village Farms International, Inc.
Consolidated Statements of Operations and Comprehensive
Income (Loss)(In thousands of United States
dollars, except per share data)
(Unaudited) |
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Sales |
|
$ |
92,182 |
|
|
$ |
77,212 |
|
|
$ |
170,259 |
|
|
$ |
141,868 |
|
Cost of sales |
|
|
(82,934) |
|
|
|
(65,713) |
|
|
|
(145,498) |
|
|
|
(118,069) |
|
Gross profit |
|
|
9,248 |
|
|
|
11,499 |
|
|
|
24,761 |
|
|
|
23,799 |
|
Selling, general and
administrative expenses |
|
|
(19,666) |
|
|
|
(16,753) |
|
|
|
(36,053) |
|
|
|
(34,158) |
|
Interest expense |
|
|
(905) |
|
|
|
(1,411) |
|
|
|
(1,822) |
|
|
|
(2,544) |
|
Interest income |
|
|
322 |
|
|
|
283 |
|
|
|
528 |
|
|
|
479 |
|
Foreign exchange (loss)
gain |
|
|
(403) |
|
|
|
738 |
|
|
|
(1,281) |
|
|
|
669 |
|
Other income |
|
|
45 |
|
|
|
5,602 |
|
|
|
149 |
|
|
|
5,632 |
|
Goodwill and intangible asset
impairments |
|
|
(11,939) |
|
|
|
— |
|
|
|
(11,939) |
|
|
|
— |
|
Loss before taxes |
|
|
(23,298) |
|
|
|
(42) |
|
|
|
(25,657) |
|
|
|
(6,123) |
|
Provision for income
taxes |
|
|
(260) |
|
|
|
(1,299) |
|
|
|
(580) |
|
|
|
(1,933) |
|
Loss including non-controlling
interests |
|
|
(23,558) |
|
|
|
(1,341) |
|
|
|
(26,237) |
|
|
|
(8,056) |
|
Less: net loss (income)
attributable to non-controlling interests, net of tax |
|
|
9 |
|
|
|
(39) |
|
|
|
(164) |
|
|
|
40 |
|
Net loss attributable to
Village Farms International, Inc. shareholders |
|
$ |
(23,549) |
|
|
$ |
(1,380) |
|
|
$ |
(26,401) |
|
|
$ |
(8,016) |
|
Basic loss per share
attributable to Village Farms International, Inc. shareholders |
|
$ |
(0.21) |
|
|
$ |
(0.01) |
|
|
$ |
(0.24) |
|
|
$ |
(0.07) |
|
Diluted loss per share
attributable to Village Farms International, Inc. shareholders |
|
$ |
(0.21) |
|
|
$ |
(0.01) |
|
|
$ |
(0.24) |
|
|
$ |
(0.07) |
|
Weighted average number of
common shares used in the computation of net loss per share (in
thousands): |
|
|
|
|
|
|
|
|
Basic |
|
|
110,960 |
|
|
|
110,239 |
|
|
|
110,604 |
|
|
|
107,185 |
|
Diluted |
|
|
110,960 |
|
|
|
110,239 |
|
|
|
110,604 |
|
|
|
107,185 |
|
Loss including non-controlling
interests |
|
$ |
(23,558) |
|
|
$ |
(1,341) |
|
|
$ |
(26,237) |
|
|
$ |
(8,056) |
|
Other comprehensive (loss)
income: |
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
(2,001) |
|
|
|
4,225 |
|
|
|
(6,252) |
|
|
|
5,087 |
|
Comprehensive (loss) gain
including non-controlling interests |
|
|
(25,559) |
|
|
|
2,884 |
|
|
|
(32,489) |
|
|
|
(2,969) |
|
Comprehensive loss (income) attributable to non-controlling
interests |
|
|
117 |
|
|
|
(361) |
|
|
|
232 |
|
|
|
(403) |
|
Comprehensive (loss) gain
attributable to Village Farms International, Inc. shareholders |
|
$ |
(25,442) |
|
|
$ |
2,523 |
|
|
$ |
(32,257) |
|
|
$ |
(3,372) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Village Farms International, Inc.
Consolidated Statements of Cash Flows (In
thousands of United States dollars)
(Unaudited) |
|
|
|
|
|
Six Months Ended June 30, |
|
|
|
2024 |
|
|
|
2023 |
|
Cash flows provided by
(used in) operating activities: |
|
|
|
|
Net loss attributable to Village Farms International, Inc.
shareholders |
|
$ |
(26,401) |
|
|
$ |
(8,016) |
|
Adjustments to reconcile net loss attributable to Village Farms
International, Inc. shareholders to net cash provided by (used in)
operating activities: |
|
|
|
|
Depreciation and amortization |
|
|
9,398 |
|
|
|
7,729 |
|
Amortization of deferred charges |
|
|
10 |
|
|
|
68 |
|
Net gain (loss) attributable to non-controlling interest |
|
|
164 |
|
|
|
(40) |
|
Interest expense |
|
|
1,822 |
|
|
|
2,544 |
|
Interest paid on long-term debt |
|
|
(2,172) |
|
|
|
(2,637) |
|
Unrealized foreign exchange loss |
|
|
172 |
|
|
|
27 |
|
Goodwill and intangible asset impairments |
|
|
11,939 |
|
|
|
— |
|
Non-cash lease expense |
|
|
1,208 |
|
|
|
907 |
|
Share-based compensation |
|
|
2,601 |
|
|
|
2,388 |
|
Deferred income taxes |
|
|
589 |
|
|
|
(392) |
|
Changes in non-cash working capital items |
|
|
6,322 |
|
|
|
(7,825) |
|
Net cash provided by (used in) operating activities |
|
|
5,652 |
|
|
|
(5,247) |
|
Cash flows (used in)
provided by investing activities: |
|
|
|
|
Purchases of property, plant and equipment |
|
|
(4,879) |
|
|
|
(2,548) |
|
Purchases of intangibles |
|
|
(80) |
|
|
|
— |
|
Acquisitions, net |
|
|
(3,016) |
|
|
|
— |
|
Repayment of note receivable |
|
|
— |
|
|
|
835 |
|
Net cash used in investing activities |
|
|
(7,975) |
|
|
|
(1,713) |
|
Cash flows (used in)
provided by financing activities: |
|
|
|
|
Repayments on borrowings |
|
|
(2,870) |
|
|
|
(6,406) |
|
Proceeds from issuance of common stock and warrants |
|
|
— |
|
|
|
24,772 |
|
Issuance costs |
|
|
— |
|
|
|
(1,437) |
|
Proceeds from exercise of stock options |
|
|
— |
|
|
|
83 |
|
Net cash (used in) provided by financing activities |
|
|
(2,870) |
|
|
|
17,012 |
|
Effect of exchange rate
changes on cash and cash equivalents |
|
|
(441) |
|
|
|
(69) |
|
Net (decrease)
increase in cash, cash equivalents and restricted
cash |
|
|
(5,634) |
|
|
|
9,983 |
|
Cash, cash equivalents
and restricted cash, beginning of period |
|
|
35,291 |
|
|
|
21,676 |
|
Cash, cash equivalents
and restricted cash, end of period |
|
$ |
29,657 |
|
|
$ |
31,659 |
|
|
|
|
|
|
|
|
|
|
Village Farms (NASDAQ:VFF)
Historical Stock Chart
From Jan 2025 to Feb 2025
Village Farms (NASDAQ:VFF)
Historical Stock Chart
From Feb 2024 to Feb 2025